CYRX: Cryoport, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 327.72
Enterprise Value ($M) 514.62
Book Value ($M) 418.57
Book Value / Share 8.47
Price / Book 0.78
NCAV ($M) 67.14
NCAV / Share 1.36
Price / NCAV 4.88

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 5.32
Current Ratio 5.70

Balance Sheet (mrq) ($M)
Current Assets 350.34
Assets 701.76
Liabilities 283.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
9 days ago 13G/A Alger Associates Inc
9 days ago 13G/A Brown Capital Management Llc
02-13 13G/A Cadian Capital Management, Lp
11-12 13G/A Vanguard Group Inc 5.74 0.00
10-16 13G/A Integrated Core Strategies (us) Llc 7.50 32.42
2024-02-08 13G Morgan Stanley 8.50
2024-01-26 13G/A BlackRock, Inc. 7.30 13.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 40,132 225,993 17.76
2025-02-20 53,809 203,562 26.43
2025-02-19 16,475 205,545 8.02
2025-02-18 28,857 172,272 16.75

(click for more detail)

Similar Companies
CVKD – Cadrenal Therapeutics, Inc. CYCC – Cyclacel Pharmaceuticals, Inc.
CYCN – Cyclerion Therapeutics, Inc. CYTH – Cyclo Therapeutics, Inc.
DARE – DarĂ© Bioscience, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.